GAINES KRISTIN SALLEE (Chief Credit Officer) received a stock award from NATIONAL HEALTH INVESTORS INC

Compensation award — not an open‑market transaction. Less informative as a directional signal.

A · 1 award

GAINES KRISTIN SALLEE

Filed: 3/5/2025ACC: 0001127602-25-008405

InsiderGAINES KRISTIN SALLEECIK 1455833

→

IssuerNATIONAL HEALTH INVESTORS INCCIK 877860

Officer· Chief Credit Officer

Since Aug 2018

+29K

Net shares

Net buyer

$0.00

Total acquired

Open market trades

0B · 0S

Total transactions

29K acquired

Non-Derivative Transactions1

Common Stock

Direct

A · Award

+4K

Price / share

—

Trade value

—

% of position

6.9%

3/3/2025

57.94K→61.94K

Total

Net shares

+4K

Net value

$0.00

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Common Stock Direct	3/3/2025	A · Award	+4K	—	—	6.9%	57.94K	61.94K
Total			+4K		$0.00

Derivative Transactions3

Stock Option (Right to Buy) 2025

Direct

A · Award

Converts to

Common Stock

8.33K shares

+8.33K

Strike price

73.34

Held after

8.33K

Exercisable

—

3/3/2025

Stock Option (Right to Buy) 2025

Direct

A · Award

Converts to

Common Stock

8.33K shares

+8.33K

Strike price

73.34

Held after

8.33K

Exercisable

—

3/3/2025

Stock Option (Right to Buy) 2025

Direct

A · Award

Converts to

Common Stock

8.33K shares

+8.33K

Strike price

73.34

Held after

8.33K

Exercisable

—

3/3/2025

Security	Converts To	Date	Type	Shares	Strike Price	Exercisable	Held After
Stock Option (Right to Buy) 2025 Direct	Common Stock8.33K shares	3/3/2025	A · Award	+8.33K	73.34	—	8.33K
Stock Option (Right to Buy) 2025 Direct	Common Stock8.33K shares	3/3/2025	A · Award	+8.33K	73.34	—	8.33K
Stock Option (Right to Buy) 2025 Direct	Common Stock8.33K shares	3/3/2025	A · Award	+8.33K	73.34	—	8.33K

Non-Derivative Holdings (Post-Transaction)0

No non-derivative holdings reported

Derivative Holdings (Post-Transaction)9

Stock Option (Right to Buy) 2024

Direct

Underlying security

Common Stock

Underlying shares

8.33K

Shares owned

8.33K

Exercise price

57.76

Expiration

—

Exercise window

—

Stock Option (Right to Buy) 2024

Direct

Underlying security

Common Stock

Underlying shares

8.33K

Shares owned

8.33K

Exercise price

57.76

Expiration

—

Exercise window

—

Stock Option (Right to Buy) 2023

Direct

Underlying security

Common Stock

Underlying shares

8.33K

Shares owned

8.33K

Exercise price

54.73

Expiration

—

Exercise window

—

Stock Option (Right to Buy) 2023

Direct

Underlying security

Common Stock

Underlying shares

8.33K

Shares owned

8.33K

Exercise price

54.73

Expiration

—

Exercise window

—

Stock Option (Right to Buy) 2024

Direct

Underlying security

Common Stock

Underlying shares

8.33K

Shares owned

8.33K

Exercise price

57.76

Expiration

—

Exercise window

—

Stock Option (Right to buy) 2022

Direct

Underlying security

Common Stock

Underlying shares

18.33K

Shares owned

18.33K

Exercise price

53.41

Expiration

—

Exercise window

—

Stock Option (Right to Buy) 2023

Direct

Underlying security

Common Stock

Underlying shares

8.33K

Shares owned

8.33K

Exercise price

54.73

Expiration

—

Exercise window

—

Stock Option (Right to buy) 2022

Direct

Underlying security

Common Stock

Underlying shares

18.33K

Shares owned

18.33K

Exercise price

53.41

Expiration

—

Exercise window

—

Stock Option (Right to buy) 2022

Direct

Underlying security

Common Stock

Underlying shares

18.33K

Shares owned

18.33K

Exercise price

53.41

Expiration

—

Exercise window

—

Total

Underlying

105K

Owned

105K

Security	Underlying	Exercise Price	Exercise Window	Expiration	Underlying Shares	Shares Owned
Stock Option (Right to Buy) 2024 Direct	Common Stock	57.76	—	—	8.33K	8.33K
Stock Option (Right to Buy) 2024 Direct	Common Stock	57.76	—	—	8.33K	8.33K
Stock Option (Right to Buy) 2023 Direct	Common Stock	54.73	—	—	8.33K	8.33K
Stock Option (Right to Buy) 2023 Direct	Common Stock	54.73	—	—	8.33K	8.33K
Stock Option (Right to Buy) 2024 Direct	Common Stock	57.76	—	—	8.33K	8.33K
Stock Option (Right to buy) 2022 Direct	Common Stock	53.41	—	—	18.33K	18.33K
Stock Option (Right to Buy) 2023 Direct	Common Stock	54.73	—	—	8.33K	8.33K
Stock Option (Right to buy) 2022 Direct	Common Stock	53.41	—	—	18.33K	18.33K
Stock Option (Right to buy) 2022 Direct	Common Stock	53.41	—	—	18.33K	18.33K
Total					105K	105K